1.32
price down icon3.65%   -0.05
after-market アフターアワーズ: 1.32
loading
前日終値:
$1.37
開ける:
$1.39
24時間の取引高:
29,393
Relative Volume:
0.35
時価総額:
$2.34M
収益:
$770.00K
当期純損益:
$-38.84M
株価収益率:
-0.0929
EPS:
-14.2049
ネットキャッシュフロー:
$-43.02M
1週間 パフォーマンス:
-25.42%
1か月 パフォーマンス:
-35.92%
6か月 パフォーマンス:
-80.44%
1年 パフォーマンス:
-86.56%
1日の値動き範囲:
Value
$1.32
$1.40
1週間の範囲:
Value
$1.32
$1.90
52週間の値動き範囲:
Value
$1.32
$37.50

Lyra Therapeutics Inc Stock (LYRA) Company Profile

Name
名前
Lyra Therapeutics Inc
Name
セクター
Healthcare (1112)
Name
電話
617-373-4600
Name
住所
480 ARSENAL WAY, WATERTOWN, MA
Name
職員
87
Name
Twitter
@LyraTx
Name
次回の収益日
2025-03-12
Name
最新のSEC提出書
Name
LYRA's Discussions on Twitter

Compare LYRA vs VRTX, REGN, ARGX, ALNY, ONC

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
LYRA
Lyra Therapeutics Inc
1.32 2.43M 770.00K -38.84M -43.02M -14.20
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
465.02 117.03B 11.74B 3.68B 3.34B 14.19
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
783.65 82.35B 14.34B 4.50B 3.77B 41.56
Biotechnology icon
ARGX
Argen X Se Adr
833.54 51.64B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
308.48 42.58B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ONC
Beone Medicines Ltd Adr
346.42 38.87B 4.98B 69.60M 525.67M 0.5198

Lyra Therapeutics Inc Stock (LYRA) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-05-07 ダウングレード BofA Securities Buy → Underperform
2024-05-07 ダウングレード H.C. Wainwright Buy → Neutral
2024-05-07 ダウングレード Jefferies Buy → Hold
2024-05-06 ダウングレード William Blair Outperform → Mkt Perform
2023-10-06 再開されました BTIG Research Buy
2023-08-31 開始されました H.C. Wainwright Buy
2022-05-24 開始されました Cantor Fitzgerald Overweight
2020-05-26 開始されました BTIG Research Buy
2020-05-26 開始されました BofA/Merrill Buy
2020-05-26 開始されました Jefferies Buy
2020-05-26 開始されました William Blair Outperform
すべてを表示

Lyra Therapeutics Inc (LYRA) 最新ニュース

pulisher
Feb 11, 2026

Analyst Upgrade: How much upside does Lyra Therapeutics Inc haveJuly 2025 Short Interest & Weekly High Return Stock Opportunities - baoquankhu1.vn

Feb 11, 2026
pulisher
Feb 11, 2026

Lyra Therapeutics Faces Nasdaq Delisting Battle After Clinical Setback - AD HOC NEWS

Feb 11, 2026
pulisher
Feb 06, 2026

Lyra Therapeutics (LYRA) Faces Nasdaq Delisting - GuruFocus

Feb 06, 2026
pulisher
Feb 06, 2026

Lyra Therapeutics Faces Nasdaq Delisting Over Shell Company Concerns, Capital Shortfall - marketscreener.com

Feb 06, 2026
pulisher
Feb 06, 2026

Lyra Therapeutics Faces Nasdaq Delisting After Becoming Shell - TipRanks

Feb 06, 2026
pulisher
Feb 06, 2026

Lyra Therapeutics Received Notice of Delisting - TradingView

Feb 06, 2026
pulisher
Feb 04, 2026

What is the dividend yield of Lyra Therapeutics IncMarket Risk Analysis & Risk Managed Investment Strategies - baoquankhu1.vn

Feb 04, 2026
pulisher
Feb 02, 2026

Aug Sectors: Can Lyra Therapeutics Inc grow without external funding2025 Performance Recap & Capital Efficiency Focused Ideas - baoquankhu1.vn

Feb 02, 2026
pulisher
Jan 29, 2026

What is the dividend yield of Lyra Therapeutics Inc.July 2025 EndofMonth & Verified Swing Trading Watchlist - mfd.ru

Jan 29, 2026
pulisher
Jan 29, 2026

Should I buy Lyra Therapeutics Inc. stock nowWeekly Profit Summary & Weekly Setup with High ROI Potential - mfd.ru

Jan 29, 2026
pulisher
Jan 28, 2026

12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga

Jan 28, 2026
pulisher
Jan 27, 2026

Downgrade Watch: Will Lyra Therapeutics Inc benefit from green energy policies2025 Retail Activity & Consistent Income Trade Recommendations - baoquankhu1.vn

Jan 27, 2026
pulisher
Jan 20, 2026

How Lyra Therapeutics Inc. stock reacts to Fed rate cutsFederal Reserve Announcements & Fast Growing Portfolio Trading - bollywoodhelpline.com

Jan 20, 2026
pulisher
Jan 18, 2026

How cyclical is Lyra Therapeutics Inc.’s revenue streamPortfolio Performance Summary & Accurate Intraday Trading Signals - Bollywood Helpline

Jan 18, 2026
pulisher
Jan 16, 2026

Weekly Buzz: LYRA Slashes Jobs; FDA Okays FBIO's ZYCUBO; BSX To Acquire PEN; BCTX On Watch - RTTNews

Jan 16, 2026
pulisher
Jan 15, 2026

Aug Spikes: Is Lyra Therapeutics Inc stock a good pick for beginnersJuly 2025 Recap & Consistent Return Strategy Ideas - baoquankhu1.vn

Jan 15, 2026
pulisher
Jan 15, 2026

Bearish Setup: Will Cheniere Energy Inc stock hit new highs in YEARWeekly Loss Report & Safe Entry Point Identification - baoquankhu1.vn

Jan 15, 2026
pulisher
Jan 14, 2026

Layoff Tracker: Lyra Shutters, EMD Serono Downsizes - BioSpace

Jan 14, 2026
pulisher
Jan 14, 2026

How much upside does Lyra Therapeutics Inc. have2025 Valuation Update & Weekly Sector Rotation Insights - Bollywood Helpline

Jan 14, 2026
pulisher
Jan 13, 2026

Take Profit: Is CRTO forming bullish engulfing patternsWeekly Trade Report & Verified Technical Signals - baoquankhu1.vn

Jan 13, 2026
pulisher
Jan 13, 2026

EV Market: Will Lyra Therapeutics Inc stock maintain momentum in 2025Analyst Downgrade & Weekly Return Optimization Plans - Bộ Nội Vụ

Jan 13, 2026
pulisher
Jan 13, 2026

Lyra Therapeutics suspends further development of LYR-210 - Yahoo Finance

Jan 13, 2026
pulisher
Jan 13, 2026

Lyra Therapeutics halts development of lead CRS treatment By Investing.com - Investing.com Nigeria

Jan 13, 2026
pulisher
Jan 12, 2026

Mass. biotech company lays off entire workforce as cash dwindles - nbcboston.com

Jan 12, 2026
pulisher
Jan 12, 2026

Gold Rises Sharply; Lyra Therapeutics Shares Plunge - Benzinga

Jan 12, 2026
pulisher
Jan 12, 2026

12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga

Jan 12, 2026
pulisher
Jan 12, 2026

Watertown biotech suspends drug development and eliminates workforce as cash dwindles - The Business Journals

Jan 12, 2026
pulisher
Jan 12, 2026

Lyra Therapeutics, Inc. Announces Termination of Jason Cavalier as Chief Financial Officer - marketscreener.com

Jan 12, 2026
pulisher
Jan 12, 2026

LYRA Plunges 55% After Company Halts Lead Program And Begins Strategic Review - Nasdaq

Jan 12, 2026
pulisher
Jan 12, 2026

Why Is Lyra Therapeutics Stock (LYRA) Down Today? - TipRanks

Jan 12, 2026
pulisher
Jan 12, 2026

Lyra Therapeutics plunges after halting development of lead nasal drug - TradingView

Jan 12, 2026
pulisher
Jan 12, 2026

Lyra Therapeutics Inc terminates CEO Maria Palasis and CFO Jason CavalierSEC filing - marketscreener.com

Jan 12, 2026
pulisher
Jan 12, 2026

Lyra Therapeutics halts development of lead CRS treatment - Investing.com

Jan 12, 2026
pulisher
Jan 12, 2026

Lyra Therapeutics Provides Corporate Update - The Manila Times

Jan 12, 2026
pulisher
Jan 09, 2026

Lyra Therapeutics, Inc. (LYRA) Reports Q1 Loss, Lags Revenue Estimates - sharewise.com

Jan 09, 2026
pulisher
Jan 08, 2026

Is Lyra Therapeutics Inc. stock attractive after correctionJuly 2025 Fed Impact & Verified Entry Point Signals - Улправда

Jan 08, 2026
pulisher
Jan 08, 2026

Can Lyra Therapeutics Inc. stock attract ESG capital inflowsWeekly Trade Review & Daily Profit Maximizing Trade Tips - Улправда

Jan 08, 2026
pulisher
Jan 08, 2026

Published on: 2026-01-08 23:57:46 - Улправда

Jan 08, 2026
pulisher
Jan 08, 2026

What momentum indicators show for Lyra Therapeutics Inc. stock2025 Support & Resistance & Free High Accuracy Swing Entry Alerts - ulpravda.ru

Jan 08, 2026
pulisher
Jan 08, 2026

ulpravda> 2026> How CHCT stock benefits from tech adoptionRecession Risk & Trade Opportunity Analysis Reports - ulpravda.ru

Jan 08, 2026
pulisher
Jan 08, 2026

Is Lyra Therapeutics Inc. stock attractive for income investors2025 Technical Patterns & Weekly Breakout Stock Alerts - Улправда

Jan 08, 2026
pulisher
Jan 08, 2026

Can Lyra Therapeutics Inc. stock sustain revenue growthSwing Trading Ideas & Our Picks = Your Future Gains - Улправда

Jan 08, 2026
pulisher
Jan 07, 2026

Breakouts Watch: How supply chain issues affect Lyra Therapeutics Inc stockWeekly Investment Recap & Real-Time Stock Entry Alerts - Bộ Nội Vụ

Jan 07, 2026
pulisher
Jan 07, 2026

Would You Accumulate or Wait on Hoac Foods India Limited (HOACFOODS)Earnings Miss Alerts & Small Investment Growth Tips - bollywoodhelpline.com

Jan 07, 2026
pulisher
Jan 06, 2026

Will Lyra Therapeutics Inc. stock outperform value stocks2025 Performance Recap & Stepwise Trade Signal Implementation - ulpravda.ru

Jan 06, 2026
pulisher
Dec 27, 2025

Lyra Therapeutics (NASDAQ:LYRA) Trading Up 0.3% – Time to Buy? - Defense World

Dec 27, 2025
pulisher
Dec 22, 2025

LYRA (Lyra Therapeutics) EV-to-OCF : -0.46 (As of Dec. 22, 2025) - GuruFocus

Dec 22, 2025
pulisher
Dec 20, 2025

Can Lyra Therapeutics Inc. stock surprise with earnings upside2025 Historical Comparison & Free AI Powered Buy and Sell Recommendations - Bölüm Sonu Canavarı

Dec 20, 2025
pulisher
Dec 20, 2025

Is Lyra Therapeutics Inc. stock a buy for dividend growthJuly 2025 Movers & Low Risk High Win Rate Stock Picks - Улправда

Dec 20, 2025
pulisher
Dec 20, 2025

Lyra Therapeutics Earnings Notes - Trefis

Dec 20, 2025
pulisher
Dec 19, 2025

Take Profit: Will Lyra Therapeutics Inc. stock outperform value stocksPortfolio Performance Report & Expert Curated Trade Setup Alerts - Улправда

Dec 19, 2025

Lyra Therapeutics Inc (LYRA) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$44.80
price up icon 1.24%
$26.75
price down icon 0.19%
$100.75
price up icon 1.93%
$105.76
price down icon 3.31%
$146.17
price down icon 1.52%
biotechnology ONC
$346.42
price down icon 1.38%
大文字化:     |  ボリューム (24 時間):